Frontlight ResearchEarly access
Parkinson disease trials in South Korea
9 of 15 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in South KoreaUnilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease.
- Where
- Seoul
- Age
- 30 years and over
- People
- 120
- Run by
- InSightec
See details and how to joinNCT07764874 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Where
- Seoul
- Age
- 50 years to 85 years
- People
- 900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00 - Phase 1Taking peoplePhase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
- Where
- Seoul
- Age
- 50 years to 80 years
- People
- 6
- Run by
- Innopeutics Corporation
See details and how to joinNCT07371338 - No phaseEnrolling by invitationEfficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease
- Where
- Daegu
- Age
- 40 years to 90 years
- People
- 50
- Run by
- Ho-Won Lee
See details and how to joinNCT07569133 - No phaseTaking peoplePersonalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients
- Where
- Seoul
- Age
- 50 years and over
- People
- 60
- Run by
- Samsung Medical Center
See details and how to joinNCT06350617 - No phaseNot yet taking people in South KoreaAmyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology
- Where
- Seoul
- Age
- 50 years to 90 years
- People
- 60
- Run by
- Yonsei University
See details and how to joinNCT07544953 - No phaseNot yet taking people in South KoreaHome-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study
- Where
- Seongnam-si
- Age
- 19 years and over
- People
- 15
- Run by
- Seoul National University Hospital
See details and how to joinNCT07522138 - No phaseTaking peopleWhole-Body Photobiomodulation for Motor and Cognitive Changes in Parkinson's Disease
- Where
- Yangsan
- Age
- 40 years and over
- People
- 15
- Run by
- Pusan National University Yangsan Hospital
See details and how to joinNCT07271927 - Phase 1Taking peopleA Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418
- Where
- Seoul
- Age
- 19 years and over
- People
- 64
- Run by
- 1ST Biotherapeutics, Inc.
See details and how to joinNCT05995782